1 citations
,
April 2022 in “Journal of The American Academy of Dermatology”
This study found that decreased pressure sensitivity and 2-pointdiscrimination at the scalp's vertex were significantly associated with androgenetic alopecia in men.
36 citations
,
November 2018 in “American Journal of Clinical Dermatology”
This review discusses the significant burden of disease and psychosocial implications associated with alopecia, highlighting its comorbidities and the impact on quality of life despite being viewed traditionally as an aesthetic concern, but reports no clinical results.
1 citations
,
February 2020 in “Journal of Cosmetic Dermatology”
In this study, the researchers found that scalp sensitivity decreased by less than 39% in patients who underwent hair transplant surgery compared to healthy controls.
91 citations
,
May 2005 in “The Journal of Clinical Endocrinology & Metabolism”
In this study, a novel mutation in the glucocorticoid receptor gene was identified in a young woman, impairing glucocorticoid signaling and leading to generalized glucocorticoid resistance.
162 citations
,
January 2015 in “Trends in Endocrinology and Metabolism”
This review discusses how women with PCOS have an increased risk of insulin resistance and cardiometabolic features regardless of body fat, and calls for targeted prevention and management strategies.
Young men experiencing hair loss are frustrated with advice to embrace baldness without exploring treatments. They advocate for using finasteride and minoxidil, considering hair transplants, and hope for future advancements in hair restoration.
The user is experimenting with a homemade topical dutasteride formulation to reduce hair loss while minimizing systemic absorption, using MCT oil, almond oil, vitamin E, tea tree oil, and lavender oil. They are monitoring hair growth and side effects, particularly focusing on sexual health, and are open to feedback on their approach.
Finasteride use resulted in increased hair growth but reduced libido for some, leading users to consider topical versions to lessen side effects. Opinions varied on the trade-off between hair benefits and sexual side effects.
Access to minoxidil and finasteride in prison is unlikely unless prescribed for medical conditions like hypertension or benign prostatic hyperplasia. Cosmetic treatments are generally not provided in prison.
A manager told an employee to stop using minoxidil, fearing it could unintentionally cause hair growth in others. The conversation is filled with humorous and sarcastic responses, questioning the manager's logic and suggesting the employee continue using the treatment secretly.